News
Evoke Pharma Announces Senior Leadership Transition With Promotion Of Matthew J. D'Onofrio To Chief Executive Officer, As Of March 31, 2024
21 Mar 24
News, Management
Recap: Evoke Pharma Q4 Earnings
14 Mar 24
Earnings
Evoke Pharma Q4 2023 GAAP EPS $(0.59) Misses $(0.50) Estimate, Sales $1.676M Beat $1.632M Estimate
14 Mar 24
Earnings, Earnings Beats, Earnings Misses, News
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
13 Mar 24
Movers
Laurence W. Lytton Reports In 13G Filing A 9.99% Stake In Evoke Pharma
13 Mar 24
News
A Preview Of Evoke Pharma's Earnings
13 Mar 24
Earnings
12 Health Care Stocks Moving In Friday's Pre-Market Session
9 Feb 24
Movers
Evoke Pharma Has Priced An Underwritten Public Offering Led By Nantahala Capital Management For Gross Proceeds Of Up To $30M Million, Which Includes Initial Upfront Funding Of Approximately $7.5M
9 Feb 24
Biotech, News, Health Care, Financing, Offerings, General
12 Health Care Stocks Moving In Tuesday's Intraday Session
23 Jan 24
Movers
Press releases
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
17 Apr 24
Health Care, Press Releases
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer
21 Mar 24
News, Management, Press Releases
Evoke Pharma Announces Closing of $7.5 Million Public Offering
14 Feb 24
News, IPOs, Press Releases
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
9 Feb 24
Press Releases